Neurofibrillary tangles are a major pathological hallmark of Alzheimer's disease (AD). These tangles contain abnormal paired helical filaments (PHF), whose primary component is tau. Tau is a neuronal microtubule associated protein that is essential for the development and maintenance of axons. Tau in tangles is abnormally phosphorylated on serines and threonines but the significance of these phosphorylations and the pathways leading to tangle formation remain unknown. The applicant now finds that tau associates with src family non-receptor tyrosine kinases, including fyn, and that tau is tyrosine phosphorylated in human neuroblastoma cells. Moreover, they find that anti-phosphotyrosine antibodies react with PHF-tau from AD brain and that anti- phosphotyrosine staining co-localizes with the anti-PHF staining of neurofibrillary lesions in AD brain. Consistent with these results, other studies find that fyn is up-regulated in AD and that an increase in tyrosine phosphorylation follows exposure of neuronal cells to A-beta peptide. Based on her findings, other studies, and the key role played by tyrosine phosphorylation in signal transduction during growth and development, the applicant hypothesizes that tyrosine phosphorylation of tau plays a critical role in neurofibrillary tangle formation in Alzheimer's disease. Here it is proposed to determine the impact of tyrosine phosphorylation on the function of tau and to assess the role of tyrosine phosphorylation of tau in tangle formation.
In Aim I, they will identify the tyrosine in tau that is phosphorylated and determine how tyrosine phosphorylation affects the function of tau.
In Aim II, they will further characterize the tyrosine phosphorylation of tau in AD brain and in their lamprey model for human tau filament assembly in situ.
In Aim III, they will determine the expression of tyrosine phosphorylation of tau during neuronal differentiation, brain development, aging and disease. These studies will help determine the role of tyrosine phosphorylation of tau in PHF assembly and may aid in the development of mouse models of AD. Moreover, since the A-beta peptide increases tyrosine phosphorylation in neuronal cells, tyrosine phosphorylation may be the link between amyloid plaque formation and neurofibrillary tangles. Insights into the tyrosine phosphorylation of tau may provide an important step forward in elucidating the pathways leading to neurofibrillary tangle formation in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG017753-04
Application #
6509711
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Snyder, Stephen D
Project Start
1999-05-01
Project End
2004-04-30
Budget Start
2002-05-15
Budget End
2003-04-30
Support Year
4
Fiscal Year
2002
Total Cost
$265,541
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kanmert, Daniel; Cantlon, Adam; Muratore, Christina R et al. (2015) C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death. J Neurosci 35:10851-65
Lee, Gloria; Leugers, Chad J (2012) Tau and tauopathies. Prog Mol Biol Transl Sci 107:263-93
Bhaskar, K; Hobbs, G A; Yen, S-H et al. (2010) Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy. Neuropathol Appl Neurobiol 36:462-77
Leugers, Chad J; Lee, Gloria (2010) Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding. J Biol Chem 285:19125-34
Bhaskar, Kiran; Yen, Shu-Hui; Lee, Gloria (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J Biol Chem 280:35119-25
Lee, Gloria; Thangavel, Ramasamy; Sharma, Vandana M et al. (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J Neurosci 24:2304-12